Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 9/2013

01-11-2013

Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study

Auteurs: Angela M. Stover, Bryce B. Reeve, Barbara F. Piper, Catherine M. Alfano, Ashley Wilder Smith, Sandra A. Mitchell, Leslie Bernstein, Kathy B. Baumgartner, Anne McTiernan, Rachel Ballard-Barbash

Gepubliceerd in: Quality of Life Research | Uitgave 9/2013

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To empirically determine clinically meaningful cut-scores on the 0–10 response scale of the revised Piper Fatigue Scale (PFS-R) and its shorter version (PFS-12). Breast cancer survivors were classified (i.e., none, mild, moderate, or severe fatigue) based on the cut-scores, and relationships between these cut-scores and decrements in health-related quality of life (HRQOL) were examined.

Methods

A total of 857 breast cancer survivors, stages in situ-IIIa, from the Health, Eating, Activity, and Lifestyle (HEAL) Study were eligible. Survivors completed the PFS-R, SF-36, and a sexual health scale approximately 3 years after diagnosis. Multivariate analysis of covariance was used to examine five fatigue severity cut-score models, controlling for demographics, clinical characteristics, comorbidity, and antidepressant use. Multivariate regression was used to examine HRQOL decrements by cut-score category.

Results

Analyses supported two similar fatigue severity cut-score models for the PFS-R and PFS-12: Model A.) none (0), mild (1–3), moderate (4–6), and severe (7–10); and Model D.) none (0), mild (1–2), moderate (3–5), and severe (6–10). For every threshold increase in fatigue severity, clinically meaningful decrements in physical, mental, and sexual health scores were observed, supporting construct validity of the fatigue cut-scores.

Conclusion

Standardized fatigue cut-scores may enhance interpretability and comparability across studies and populations and guide treating planning.
vorige artikel Does providing feedback on patient-reported outcomes to healthcare professionals result in better outcomes for patients? A systematic review
volgende artikel Quality-of-life loss of people admitted to burn centers, United States
Literatuur
1.
Meeske, K., Smith, A. W., Alfano, C. M., McGregor, B. A., McTiernan, A., Baumgartner, K. B., et al. (2007). Fatigue in breast cancer survivors two to five years post diagnosis: A HEAL Study report. Quality of Life Research, 16, 947–960.PubMedCrossRef
2.
Kim, J.-E., Dodd, M. J., Aouizerat, B. E., Jahan, T., & Miaskowski, C. (2009). A review of the prevalence and impact of multiple symptoms in oncology patients. Journal of Pain and Symptom Management, 37, 715–736.CrossRef
3.
Scott, J. A., Lasch, K., Barsevick, A., & Piault-Louis, E. (2011). Patient-reported outcomes of fatigue consortium (PROOF-C). Patients’ experiences with cancer-related fatigue: A systematic review and synthesis of qualitative research. Oncology Nursing Forum, 38, E191–E203.PubMedCrossRef
4.
Ganz, P. A., Desmond, K. A., Leedham, B., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2002). Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. Journal of the National Cancer Institute, 94, 39–49.PubMedCrossRef
5.
Mitchell, S. (2010). Cancer-related fatigue: State of the science. Physical Medicine and Rehabilitation, 2, 364–383.
6.
Piper, B. F., & Cella, D. (2010). Cancer-related fatigue: definitions and clinical subtypes. Journal of the National Comprehensive Cancer Network, 8, 958–966.PubMed
7.
Knowles, G., Borthwick, D., McNamara, S., Miller, M., & Leggot, L. (2000). Survey of nurses’ assessment of cancer-related fatigue. European Journal of Cancer Care, 9, 105–113.PubMedCrossRef
8.
Pachman, D. R., Barton, D. L., Swetz, K. M., & Loprinzi, C. L. (2012). Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. Journal of Clinical Oncology, 30, 3687–3696.PubMedCrossRef
9.
Barsevick, A. M., & Cleeland, C. S. (2010). ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. Journal of Pain and Symptom Management, 39, 1086–1099.PubMedCrossRef
10.
The Cancer-Related Fatigue Guidelines (Version 4.2007) in The Complete Library of NCCN Clinical Practice Guidelines in Oncology [CD-ROM] Jenkintown, Pennsylvania: © 2006 National Comprehensive Cancer Network, Inc.; Mar, 2008. To view the most recent and complete version of the guideline, go to www.​nccn.​org.
11.
Berger, A. M., Abernethy, A. P., & Atkinson, A. (2010). Cancer-related fatigue. JNCCN, 8, 904–931.PubMed
12.
Mitchell, S. A., Beck, S. L., & Eaton, L. H. (2009). ONS putting evidence into practice (PEP): fatigue. In L. H. Eaton & J. M. Tipton (Eds.), Putting evidence into practice. Pittsburgh: Oncology Nursing Society.
13.
Cella, D., Davis, K., Breitbart, W., Curt, G., for the Fatigue Coalition. (2001). Cancer-related fatigue: Prevalence of proposed diagnostic criteria in a United States sample of cancer survivors. Journal of Clinical Oncology, 19, 3385–3391.
14.
Cella, D., Peterman, A., Passik, S., et al. (1998). Progress towards guidelines for the management of fatigue. Oncology, 12, 369–377.PubMed
15.
Vogelzang, N., Breitbart, W., Cella, D., et al. (1997). Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tri-part assessment survey. Seminars in Hematology, 34(Supplement 2), 4–12.PubMed
16.
Agasi-Idenburg, C., Velthuis, M., & Wittink, H. (2010). Quality criteria and user-friendliness in self-reported questionnaires on cancer-related fatigue: A review. Journal of Clinical Epidemiology, 63, 705–711.PubMedCrossRef
17.
Dittner, A. J., Wessely, S. C., & Brown, R. G. (2004). The assessment of fatigue: A practical guide for clinicians and researchers. Journal of Psychosomatic Research, 56, 157–170.PubMedCrossRef
18.
Jean-Pierre, P., & Figueroa-Moseley, C. D. (2007). Assessment of cancer-related fatigue: Implications for clinical diagnosis and treatment. Oncologist, 12(Supplement 1), 11–21.PubMedCrossRef
19.
Minton, O., & Stone, P. (2009). A systematic review of the scales used for the measurement of cancer-related fatigue (CRF). Annals of Oncology, 20, 17–25.PubMedCrossRef
20.
Mota, D. D., & Pimenta, C. A. (2006). Self-report instruments for fatigue assessment: A systematic review. Research and Theory for Nursing Practice, 20, 49–78.PubMedCrossRef
21.
Whitehead, L. (2009). The measurement of fatigue in chronic illness: A systematic review of unidimensional and multidimensional fatigue measures. Journal of Pain and Symptom Management, 37, 107–128.PubMedCrossRef
22.
Mendoza, T., Wang, X. S., Cleeland, C. S., Morrissey, M., Johnson, B. A., Wendt, J. K., et al. (1999). The rapid assessment of fatigue severity in cancer patients: Use of the brief fatigue inventory. Cancer, 85, 1186–1196.PubMedCrossRef
23.
Borneman, T., Koczywas, M., Sun, V. C., Piper, B. F., Uman, G., & Ferrell, B. (2010). Reducing patient barriers to pain and fatigue management. Journal of Pain and Symptom Management, 39, 486–501.PubMedCrossRef
24.
Weilgus, K., Berger, A. M., & Hertzog, M. (2009). Predictors of fatigue 30 days after completing anthracycline plus taxane adjuvant chemotherapy for breast cancer. Oncology Nursing Forum, 36, 38–48.CrossRef
25.
Cullum, J. L., Wojciechowski, A. E., & Simpson, J. S. A. (2004). Bupropion sustained release treatment reduces fatigue in cancer patients. Canadian Journal of Psychiatry, 49, 139–144.
26.
Cooper, M. R., Bird, H. M., & Steinberg, M. (2009). Efficacy and safety of modafinil in the treatment of cancer-related fatigue. The Annals of Pharmacotherapy, 43, 721–725.PubMedCrossRef
27.
Jean-Pierre, P., Morrow, G. R., Roscoe, J. A., Heckler, C., Mohile, S., Janelsins, M., et al. (2010). A phase 3 randomized, placebo-controlled, doubleblind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: A University of Rochester cancer center community clinical oncology program research base study. Cancer, 116, 3513–3520.PubMedCrossRef
28.
Moss, E. L., Simpson, J. S., Pelletier, G., et al. (2006). An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners. Psycho-oncology, 15, 259–267.PubMedCrossRef
29.
Nering, M. L., & Ostini, R. (Eds.). (2010). Handbook of polytomous item response theory models. New York, NY: Routledge.
30.
Chamberlain Wilmoth, M., Coleman, E. A., Smith, S. C., & Davis, C. (2004). Fatigue, weight gain, and altered sexuality in patients with breast cancer: Exploration of a symptom cluster. Oncology Nursing Forum, 31, 1069–1075.CrossRef
31.
Webber, K., Mok, K., Bennett, B., Lloyd, A. R., Friedlander, M., Juraskova, I., et al. (2011). If I am in the mood, I enjoy it: An exploration of cancer-related fatigue and sexual functioning in women with breast cancer. The Oncologist, 16, 1333–1344.PubMedCrossRef
32.
Ganz, P. A., Rowland, J. H., Desmond, K., Meyerowitz, B. E., & Wyatt, G. E. (1998). Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. Journal of Clinical Oncology, 16, 501–514.PubMed
33.
Ganz, P. A., Desmond, K. A., Belin, T. R., Meyerowitz, B. E., & Rowland, J. H. (1999). Predictors of sexual health in women after a breast cancer diagnosis. Journal of Clinical Oncology, 17, 2371–2380.PubMed
34.
Fobair, P., & Spiegel, D. (2010). Concerns about sexuality after breast cancer. In V. T. Devita, T. S. Lawrence, & S. A. Rosenberg (Eds.), Cancer principles and practice of oncology: Annual advances in oncology (pp. 7–14). Philadelphia, PA: Lippincott Williams & Wilkins.
35.
Lindau, S. T., Schumm, L. P., Laumann, E. O., Levinson, W., O’Muircheartaigh, C. A., & Waite, L. J. (2007). A study of sexuality and health among older adults in the United States. New England Journal of Medicine, 357, 762–774.PubMedCrossRef
36.
Rubin, P. (2001). Clinical oncology: A multidisciplinary approach for physicians and students (8th ed.). Philadelphia: W. B. Saunders Company.
37.
Piper, B. F., Dibble, S. L., Dodd, M. J., Weiss, M. C., Slaughter, R. E., & Paul, S. M. (1998). The revised piper fatigue scale: Psychometric evaluation in women with breast cancer. Oncology Nursing Forum, 25, 677–684.PubMed
38.
Reeve, B. B., Stover, A. M., Alfano, C. M., Piper, B. F., Bernstein, L., Baumgartner, K., et al. (2012). Psychometric evaluation and reduction of the piper fatigue scale based on a cohort of breast cancer survivors. Breast Cancer Research and Treatment, 136, 9–20.PubMedCrossRef
39.
McTiernan, A., Rajan, K. B., Tworoger, S. S., Irwin, M., Bernstein, L., Baumgartner, R., et al. (2003). Adiposity and sex hormones in postmenopausal breast cancer survivors. Journal of Clinical Oncology, 21, 1961–1966.PubMedCrossRef
40.
Groenvold, M., Aagard Petersen, M., Idler, E., Bjorner, J. B., Fayers, P. M., & Mouridsen, H. T. (2007). Psychological distress and fatigue predicted recurrence and survival in primary breast cancer patients. Breast Cancer Research and Treatment, 105, 209–219.PubMedCrossRef
41.
Ware, J. E., & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30, 473–483.PubMedCrossRef
42.
Schag, C. A. C., Heinrich, R. L., Aadland, R. L., & Ganz, P. A. (1990). Assessing problems of cancer patients: Psychometric properties of the Cancer Inventory of Problem Situations (CIPS). Health Psychology, 9, 83–102.PubMedCrossRef
43.
Bjorner, J. B., Wallenstein, G. V., Martin, M. C., Lin, P., Piech Blaisdell-Gross, C. T., et al. (2007). Interpreting score differences in the SF-36 Vitality scale: Using clinical conditions and functional outcomes to define the minimally important difference. Current Medical Research and Opinions, 23, 731–739.CrossRef
44.
Norman, G. R., Sloan, J. A., & Wyrwich, K. W. (2003). Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Medical Care, 41, 582–592.PubMed
45.
Revicki, D., Hays, R., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61, 102–109.PubMedCrossRef
46.
Sloan, J., Cella, D., & Hays, R. (2005). Clinical significance of patient-reported questionnaire data: Another step toward consensus. Journal of Clinical Epidemiology, 58, 1217–1219.PubMedCrossRef
47.
Schwartz, A. L., Meek, P. M., Nail, L., Fargo, J., Lundquist, M., Donofrio, M., et al. (2002). Measurement of fatigue: determining minimally important differences. Journal of Clinical Epidemiology, 55, 239–244.PubMedCrossRef
48.
American Joint Committee on Cancer. (2010). AJCC cancer staging handbook (7th ed.). Chicago: Author.CrossRef
49.
Hand, D. J., & Taylor, C. C. (1987). Multivariate analysis of variance and repeated measures. London: Chapman and Hall.CrossRef
50.
Davies, N., Gibbons, E., Mackintosh, A., Fitzpatrick, R. On behalf of the Oxford Patient-Reported Outcomes Measurement Group (2009). A structured review of patient-reported outcome measures (PROMs) for women with breast cancer. Oxford: University of Oxford.
51.
Wilson, R. W., Hutson, L. M., & VanStry, D. (2005). Comparison of 2 quality-of-life questionnaires in women treated for breast cancer: The RAND 36-Item health survey and the functional living index–cancer. Physical Therapy, 85, 851–860.PubMed
52.
Bower, J. E., Ganz, P. A., Desmond, K. A., Rowland, J. H., Meyerowitz, B. E., & Belin, T. R. (2000). Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. Journal of Clinical Oncology, 18, 743–749.PubMed
53.
Merle, M. E. (1998). Correlates of fatigue in survivors of breast cancer. Cancer Nursing, 21, 136–142.CrossRef
54.
Haghighat, S., Esmail Akbari, M., Holakouei, K., Rahimi, A., & Montazeri, A. (2003). Factors predicting fatigue in breast cancer patients. Supportive Care in Cancer, 11, 533–538.PubMedCrossRef
55.
Day, R., Ganz, P. A., Costantino, J. P., Cronin, W. M., Wickerman, D. L., & Fisher, B. (1999). Health-related quality of life and tamoxifen in breast cancer prevention: A report from the national surgical adjuvant breast and bowel project P-1 study. Journal of Clinical Oncology, 17, 2659–2669.PubMed
56.
de Jong, N., Courtens, A. M., Abu-Saad, H. H., & Schouten, H. C. (2002). Fatigue in patients with breast cancer receiving adjuvant chemotherapy: A review of the literature. Cancer Nursing, 25, 283–297.PubMedCrossRef
57.
Lin, N. U., Vanderplas, A., Hughes, M. E., Theriault, R. L., Edge, S. B., Wong, Y.-N., et al. (2012). Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the national comprehensive cancer network. Cancer, 118, 5463–5472.PubMedCrossRef
58.
Rakka, E. A., El-Sayed, M. E., Green, A. R., Lee, A. H. S., Robertson, J. F., & Ellis, I. O. (2007). Prognostic markers in triple-negative breast cancer. Cancer, 109, 25–32.CrossRef
59.
Anderson, W. F., Chu, K. C., Chatterjee, N., Brawley, O., & Brinton, L. A. (2001). Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance, epidemiology, and end results database. Journal of Clinical Oncology, 19, 18–27.PubMed
60.
Pilkonis, P. A., Choi, S. W., Reise, S. P., Stover, A. M., Riley, W. T., & Cella, D. (2011). Item banks for measuring emotional distress from the patient-reported outcomes measurement information system (PROMIS): Depression, anxiety, & anger. Assessment, 18, 263–283.PubMedCrossRef
Metagegevens
Titel
Deriving clinically meaningful cut-scores for fatigue in a cohort of breast cancer survivors: a Health, Eating, Activity, and Lifestyle (HEAL) Study
Auteurs
Angela M. Stover
Bryce B. Reeve
Barbara F. Piper
Catherine M. Alfano
Ashley Wilder Smith
Sandra A. Mitchell
Leslie Bernstein
Kathy B. Baumgartner
Anne McTiernan
Rachel Ballard-Barbash
Publicatiedatum
01-11-2013
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 9/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0360-6

Andere artikelen Uitgave 9/2013

Quality of Life Research 9/2013 Naar de uitgave

Commentary

Pitfalls in subgroup analysis based on growth mixture models: a commentary on van Leeuwen et al. (2012)

Review

Health status and (health-related) quality of life during the recovery of distal radius fractures: a systematic review

OriginalPaper

Psychometric validation of the physician global assessment scale for assessing severity of psoriasis disease activity

OriginalPaper

Using group-based trajectory modeling to examine heterogeneity of symptom burden in patients with head and neck cancer undergoing aggressive non-surgical therapy

OriginalPaper

Development and psychometric properties of the PROMIS® pediatric fatigue item banks

Brief Communication

Comparison of the responsiveness of the SF-36, the Oxford Knee Score, and the Knee Society Clinical Rating System in patients undergoing total knee replacement